We are live on ! Find out more
ARMC

American Research & Management Company Portfolio holdings

AUM $362M
1-Year Est. Return 8.06%
This Fund
S&P 500
This Quarter Est. Return
+11.83%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
AUM
$384M
AUM Growth
+$42.1M
Cap. Flow
+$6.1M
Cap. Flow %
1.59%
Top 10 Hldgs %
33.42%
Holding
402
New
39
Increased
71
Reduced
55
Closed
20

Top Sells

Rank Stock Value
1
IAU icon
iShares Gold Trust
IAU
+$1.7M
2
NVDA icon
NVIDIA
NVDA
+$477K
3
ET icon
Energy Transfer Partners
ET
+$408K
4
IBM icon
IBM
IBM
+$398K
5
MCD icon
McDonald's
MCD
+$344K

Sector Composition

Rank Sector Weight
1 Technology 25.59%
2 Healthcare 14.79%
3 Consumer Staples 13.71%
4 Miscellaneous 12.81%
5 Financials 12.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.67T
$15.6M 4.06%
117,726
-80
-0.1% -$9.62K
IBM icon
2
IBM
IBM
$222B
$15.4M 4.01%
128,009
-3,442
-3% -$398K
ADI icon
3
Analog Devices
ADI
$175B
$14.5M 3.77%
98,214
-885
-0.9% -$117K
ADBE icon
4
Adobe
ADBE
$116B
$14.2M 3.69%
28,386
-150
-0.5% -$72.5K
IAU icon
5
iShares Gold Trust
IAU
$66.1B
$13.9M 3.62%
383,830
-47,388
-11% -$1.7M
JNJ icon
6
Johnson & Johnson
JNJ
$646B
$11.9M 3.08%
75,316
+1,457
+2% +$215K
CHD icon
7
Church & Dwight Co
CHD
$24B
$11.4M 2.96%
130,649
-2,274
-2% -$201K
PYPL icon
8
PayPal
PYPL
$45.9B
$11.2M 2.92%
47,862
+90
+0.2% +$18.6K
FISV
9
Fiserv Inc
FISV
$28.3B
$10.9M 2.83%
95,686
-1,335
-1% -$144K
PG icon
10
Procter & Gamble
PG
$334B
$9.47M 2.46%
68,051
+375
+0.6% +$52.4K
WAT icon
11
Waters Corp
WAT
$40.7B
$9.21M 2.4%
37,227
-143
-0.4% -$32.4K
PEP icon
12
PepsiCo
PEP
$193B
$9.02M 2.35%
60,811
+1,009
+2% +$143K
ITW icon
13
Illinois Tool Works
ITW
$79.8B
$8.93M 2.32%
43,816
-150
-0.3% -$30.7K
GBCI icon
14
Glacier Bancorp
GBCI
$6.1B
$8.65M 2.25%
188,099
AMZN icon
15
Amazon
AMZN
$2.87T
$8.58M 2.23%
52,700
+720
+1% +$115K
AMLP icon
16
Alerian MLP ETF
AMLP
$13.4B
$8.22M 2.14%
320,204
-150
-0% -$3.6K
NVDA icon
17
NVIDIA
NVDA
$5.25T
$7.95M 2.07%
608,720
-35,640
-6% -$477K
DOV icon
18
Dover
DOV
$26.8B
$7.92M 2.06%
62,725
-1,745
-3% -$207K
SCHW
19
Charles Schwab
SCHW
$191B
$7.22M 1.88%
136,166
+722
+0.5% +$32.7K
XOM icon
20
ExxonMobil
XOM
$644B
$6.65M 1.73%
161,320
-1,266
-0.8% -$47.5K
FNV icon
21
Franco-Nevada
FNV
$51.3B
$6.46M 1.68%
51,579
+27,002
+110% +$3.64M
MSFT icon
22
Microsoft
MSFT
$3.81T
$6.38M 1.66%
28,685
+1,719
+6% +$370K
CVX icon
23
Chevron
CVX
$396B
$5.46M 1.42%
64,671
+5,331
+9% +$432K
NVS icon
24
Novartis
NVS
$292B
$5.33M 1.39%
56,431
-50
-0.1% -$4.37K
PAYX icon
25
Paychex
PAYX
$45.2B
$5.04M 1.31%
54,050
-49
-0.1% -$4.35K

Similar funds

American Research & Management Company's Q4 2020 Portfolio in Review

As of Q4 2020, American Research & Management Company held 402 positions worth $384M, up 12% from $342M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

American Research & Management Company's Q4 2020 filing shows 39 new, 71 increased, 55 reduced and 20 closed positions. Its largest new stake was Vertex Pharmaceuticals: 9,888 shares worth $2.34M. The largest sale was iShares Gold Trust, an estimated $1.7M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Staples.

  • American Research & Management Company's largest Q4 2020 buy was Vertex Pharmaceuticals: 9,888 shares worth $2.34M.
  • American Research & Management Company added most to Franco-Nevada in Q4 2020, an estimated $3.64M increase.
  • American Research & Management Company's biggest Q4 2020 reduction was iShares Gold Trust, cutting an estimated $1.7M.
  • American Research & Management Company fully exited iShares Russell Mid-Cap Growth ETF in Q4 2020, selling an estimated $25K.
  • American Research & Management Company's ten largest holdings make up 33% of its $384M portfolio in Q4 2020.
  • American Research & Management Company opened 39 new positions and closed 20 in Q4 2020.
  • American Research & Management Company's portfolio value rose 12% quarter-over-quarter to $384M.

Based on American Research & Management Company's 13F filing for Q4 2020, filed 28 Jan 2021.